141 related articles for article (PubMed ID: 6162544)
1. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
Juranka P; Chan VL
Cancer Res; 1980 Nov; 40(11):4123-6. PubMed ID: 6162544
[TBL] [Abstract][Full Text] [Related]
2. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Shewach DS; Plunkett W
Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
[TBL] [Abstract][Full Text] [Related]
3. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
Helland S; Ueland PM
Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
Cass CE; Tan TH; Selner M
Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
[TBL] [Abstract][Full Text] [Related]
5. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nuclear envelope nucleoside triphosphatase-regulated nucleocytoplasmic messenger RNA translocation by 9-beta-D-arabinofuranosyladenine 5'-triphosphate in rodent cells.
Schröder HC; Nitzgen DE; Bernd A; Kurelec B; Zahn RK; Gramzow M; Müller WE
Cancer Res; 1984 Sep; 44(9):3812-9. PubMed ID: 6204747
[TBL] [Abstract][Full Text] [Related]
7. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
Fridland A
Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
[TBL] [Abstract][Full Text] [Related]
8. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
Cass CE; Selner M; Phillips JR
Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
[TBL] [Abstract][Full Text] [Related]
9. Codominant and recessive 9-beta-D-arabinofuranosyladenine-resistant mutations of baby hamster cells.
Chan VL; Guttman S
Mutat Res; 1985 Mar; 149(1):141-6. PubMed ID: 3974620
[TBL] [Abstract][Full Text] [Related]
10. Cellular retention of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and the pattern of recovery of DNA synthesis in Chinese hamster ovary cells.
Shewach DS; Plunkett W
Cancer Res; 1986 Apr; 46(4 Pt 1):1581-4. PubMed ID: 2418951
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
12. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
Kufe DW; Major PP; Munroe D; Egan M; Herrick D
Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
[TBL] [Abstract][Full Text] [Related]
13. Conjugates of 9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) with lactosaminated albumin. Characterization of the drug-carrier bonds.
Fiume L; Bassi B; Bongini A
Pharm Acta Helv; 1988; 63(4-5):137-9. PubMed ID: 2464835
[No Abstract] [Full Text] [Related]
14. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
Kufe D; Herrick D; Crumpacker C; Schnipper L
Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Cass CE; Au-Yeung TH
Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
[TBL] [Abstract][Full Text] [Related]
17. Differential composition of cytosol 5'-nucleotidases between T and B lymphoblasts.
Iizasa T; Takeuchi F; Honda Z; Nishida Y; Kamatani N; Miyamoto T
Biochim Biophys Acta; 1986 Jun; 882(2):228-33. PubMed ID: 3011114
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
White EL; Shaddix SC; Brockman RW; Bennett LL
Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus.
Ono K; Ohashi A; Yamamoto A; Matsukage A; Takahasi T; Saneyoshi M; Ueda T
Cancer Res; 1979 Nov; 39(11):4673-80. PubMed ID: 91427
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
Ayisi NK; Meldrum JB; Stuart AL; Gupta VS
Antiviral Res; 1983 Sep; 3(3):161-74. PubMed ID: 6197027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]